Condition: Polycystic Ovary Syndrome (PCOS) · Sponsor: Mst.Sumyara Khatun
The goal of this clinical trial is to learn if combination of levocarnitine and myoinositol works better than myoinositol alone on insulin resistance and hormonal parameters in subfertile women with insulin resistant polycystic ovary syndrome . It will also learn about the safety of drug levocarnitine and myoinositol. The main questions it aims to answer are: Does combined action of levocarnitine and myoinositol improve insulin resistance and hormonal parameters in comparison to myoinositol alone in subfertile women with insulin resistant polycystic ovary syndrome ? What medical problems do participants have when taking drug levocarnitine and myoinositol? Researchers will compare the drug combination of levocarnitine and myoinositol to myoinositol alone to see if combination therapy works better? Participants will: Take drug levocarnitine and myoinositol or a myoinositol alone twice daily for 3 months Visit the clinic once after 3 months for checkups and tests Keep a diary of their symptoms and the number of times.
This description comes directly from the study's public registry record.
Mst.Sumyara Khatun, MS · +8801746046581 · sumirmc09@gmail.com
Mst Rebeka sultana, MBBS · +8801752011780 · drrebeka39bcs@gmail.com
Always discuss trial participation with your own doctor first.
| Bangladesh Medical University | Dhaka, Shahbag, Bangladesh | Not Yet Recruiting |
| Bangladesh Medical University | Dhaka, Shahbag, Bangladesh | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07266259